Compare · FMS vs QIPT
FMS vs QIPT
Side-by-side comparison of Fresenius Medical Care AG (FMS) and Quipt Home Medical Corp. (QIPT): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FMS and QIPT operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- FMS is the larger of the two at $12.72B, about 76.3x QIPT ($166.8M).
- Over the past year, FMS is down 9.1% and QIPT is up 71.1% - QIPT leads by 80.3 points.
- FMS has hit the wire 1 time in the past 4 weeks while QIPT has been quiet.
- FMS has more recent analyst coverage (21 ratings vs 6 for QIPT).
- Company
- Fresenius Medical Care AG
- Quipt Home Medical Corp.
- Price
- $22.76+0.02%
- $3.65+0.00%
- Market cap
- $12.72B
- $166.8M
- 1M return
- +2.18%
- +2.24%
- 1Y return
- -9.14%
- +71.13%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 1
- 0
- Recent ratings
- 21
- 6
Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Quipt Home Medical Corp.
Quipt Home Medical Corp. provides in-home monitoring equipment and disease management services includes end-to-end respiratory solutions for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, nebulizers, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; and home ventilator equipment, as well as rents respiratory equipment. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Latest FMS
- SEC Form 6-K filed by Fresenius Medical Care AG
- SEC Form 3 filed by Fresenius Medical Care AG
- SEC Form 6-K filed by Fresenius Medical Care AG
- SEC Form IRANNOTICE filed by Fresenius Medical Care AG
- SEC Form 20-F filed by Fresenius Medical Care AG
- Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
- SEC Form 6-K filed by Fresenius Medical Care AG
- Fresenius Medical downgraded by Goldman
- SEC Form 6-K filed by Fresenius Medical Care AG
- Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
Latest QIPT
- SEC Form 15-12G filed by Quipt Home Medical Corp.
- Amendment: SEC Form SCHEDULE 13D/A filed by Quipt Home Medical Corp.
- Director Wessel Brian Joseph returned $787,411 worth of shares to the company (215,729 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Accounting Officer Roehrig Thomas returned $631,450 worth of shares to the company (173,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Chief Compliance Officer Miles Mark Alan returned $401,500 worth of shares to the company (110,000 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Greenberg Mark Alan returned $1,589,418 worth of shares to the company (435,457 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Gamble Patrick Dennis returned $219,208 worth of shares to the company (60,057 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- President/CEO Crawford Gregory John returned $16,755,427 worth of shares to the company (4,590,528 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Director Carter Kevin A. returned $734,234 worth of shares to the company (201,160 units at $3.65), closing all direct ownership in the company (SEC Form 4)
- Exec. VP Operations Bachelder David returned $80,869 worth of shares to the company (22,156 units at $3.65), closing all direct ownership in the company (SEC Form 4)